Alaunos Therapeutics (TCRT)
(Delayed Data from NSDQ)
$2.42 USD
-0.08 (-3.20%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.42 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TCRT 2.42 -0.08(-3.20%)
Will TCRT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TCRT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TCRT
Crossed Above 200 Day Moving Average appears for TCRT after 4.17% move
NR7 appears for TCRT after 3.45% move
NR7 appears for TCRT after 3.11% move
Is TCRT lining up for a decline? Non-ADX 1,2,3,4 Bearish shows up after slipping 2.6%
Technical picture remains unchanged for TCRT after it falls 2.94% on September 12